全文获取类型
收费全文 | 124290篇 |
免费 | 9773篇 |
国内免费 | 8677篇 |
专业分类
142740篇 |
出版年
2024年 | 253篇 |
2023年 | 1636篇 |
2022年 | 3590篇 |
2021年 | 6040篇 |
2020年 | 4023篇 |
2019年 | 4921篇 |
2018年 | 4927篇 |
2017年 | 3619篇 |
2016年 | 5108篇 |
2015年 | 7431篇 |
2014年 | 8824篇 |
2013年 | 9335篇 |
2012年 | 11285篇 |
2011年 | 10112篇 |
2010年 | 6244篇 |
2009年 | 5564篇 |
2008年 | 6461篇 |
2007年 | 5747篇 |
2006年 | 5048篇 |
2005年 | 3920篇 |
2004年 | 3472篇 |
2003年 | 3020篇 |
2002年 | 2618篇 |
2001年 | 2291篇 |
2000年 | 2134篇 |
1999年 | 2078篇 |
1998年 | 1183篇 |
1997年 | 1271篇 |
1996年 | 1147篇 |
1995年 | 1001篇 |
1994年 | 1043篇 |
1993年 | 718篇 |
1992年 | 1068篇 |
1991年 | 900篇 |
1990年 | 669篇 |
1989年 | 593篇 |
1988年 | 512篇 |
1987年 | 426篇 |
1986年 | 403篇 |
1985年 | 411篇 |
1984年 | 220篇 |
1983年 | 209篇 |
1982年 | 150篇 |
1981年 | 117篇 |
1980年 | 110篇 |
1979年 | 117篇 |
1978年 | 83篇 |
1977年 | 62篇 |
1974年 | 77篇 |
1972年 | 65篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Xin Deng Guoli Zhang Ling Zhang Yan Feng Zehong Li GuangMou Wu Yuhuan Yue Gensong Li Yu Cao Ping Zhu 《PloS one》2015,10(11)
Non-viral gene delivery system with many advantages has a great potential for the future of gene therapy. One inherent obstacle of such approach is the uptake by endocytosis into vesicular compartments. Receptor-mediated gene delivery method holds promise to overcome this obstacle. In this study, we developed a receptor-mediated gene delivery system based on a combination of the Pseudomonas exotoxin A (PE), which has a receptor binding and membrane translocation domain, and the hyperthermophilic archaeal histone (HPhA), which has the DNA binding ability. First, we constructed and expressed the rPE-HPhA fusion protein. We then examined the cytotoxicity and the DNA binding ability of rPE-HPhA. We further assessed the efficiency of transfection of the pEGF-C1 plasmid DNA to CHO cells by the rPE-HPhA system, in comparison to the cationic liposome method. The results showed that the transfection efficiency of rPE-HPhA was higher than that of cationic liposomes. In addition, the rPE-HPhA gene delivery system is non-specific to DNA sequence, topology or targeted cell type. Thus, the rPE-HPhA system can be used for delivering genes of interest into mammalian cells and has great potential to be applied for gene therapy. 相似文献
102.
Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity. 总被引:4,自引:2,他引:2
下载免费PDF全文
![点击此处可从《Molecular and cellular biology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
103.
A Positive GATA Element and a Negative Vitamin D Receptor-Like Element Control Atrial Chamber-Specific Expression of a Slow Myosin Heavy-Chain Gene during Cardiac Morphogenesis 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Molecular and cellular biology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Gang Feng Wang William Nikovits Jr. Mark Schleinitz Frank E. Stockdale 《Molecular and cellular biology》1998,18(10):6023-6034
We have used the slow myosin heavy chain (MyHC) 3 gene to study the molecular mechanisms that control atrial chamber-specific gene expression. Initially, slow MyHC 3 is uniformly expressed throughout the tubular heart of the quail embryo. As cardiac development proceeds, an anterior-posterior gradient of slow MyHC 3 expression develops, culminating in atrial chamber-restricted expression of this gene following chamberization. Two cis elements within the slow MyHC 3 gene promoter, a GATA-binding motif and a vitamin D receptor (VDR)-like binding motif, control chamber-specific expression. The GATA element of the slow MyHC 3 is sufficient for expression of a heterologous reporter gene in both atrial and ventricular cardiomyocytes, and expression of GATA-4, but not Nkx2-5 or myocyte enhancer factor 2C, activates reporter gene expression in fibroblasts. Equivalent levels of GATA-binding activity were found in extracts of atrial and ventricular cardiomyocytes from embryonic chamberized hearts. These observations suggest that GATA factors positively regulate slow MyHC 3 gene expression throughout the tubular heart and subsequently in the atria. In contrast, an inhibitory activity, operating through the VDR-like element, increased in ventricular cardiomyocytes during the transition of the heart from a tubular to a chambered structure. Overexpression of the VDR, acting via the VDR-like element, duplicates the inhibitory activity in ventricular but not in atrial cardiomyocytes. These data suggest that atrial chamber-specific expression of the slow MyHC 3 gene is achieved through the VDR-like inhibitory element in ventricular cardiomyocytes at the time distinct atrial and ventricular chambers form. 相似文献
104.
105.
106.
107.
108.
109.
110.